🇺🇸 AZD6094 in United States

21 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 3 reports (14.29%)
  2. Aspartate Aminotransferase Increased — 3 reports (14.29%)
  3. Pyrexia — 3 reports (14.29%)
  4. Acute Kidney Injury — 2 reports (9.52%)
  5. Anaphylactic Reaction — 2 reports (9.52%)
  6. Drug Hypersensitivity — 2 reports (9.52%)
  7. Dyspnoea — 2 reports (9.52%)
  8. Neutrophil Count Decreased — 2 reports (9.52%)
  9. Arthralgia — 1 report (4.76%)
  10. Blood Creatinine Increased — 1 report (4.76%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is AZD6094 approved in United States?

AZD6094 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for AZD6094 in United States?

Samsung Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.